ID   HPAF/CD11
AC   CVCL_B285
SY   HPAF-CD11; CD11/HPAF; CD11; CD-11; CD 11
DR   cancercelllines; CVCL_B285
DR   Cosmic; 922246
DR   Wikidata; Q54890232
RX   PubMed=2734279;
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=2734279).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B284 ! HPAF
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 16
//
RX   PubMed=2734279; DOI=10.1097/00006676-198906000-00013;
RA   Kim Y.W., Kern H.F., Mullins T.D., Koriwchak M.J., Metzgar R.S.;
RT   "Characterization of clones of a human pancreatic adenocarcinoma cell
RT   line representing different stages of differentiation.";
RL   Pancreas 4:353-362(1989).
//